Effect of beta‐blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy von Wheeler, Matthew T., Jacoby, Daniel, Elliott, Perry M., Saberi, Sara, Hegde, Sheila M., Lakdawala, Neal K., Myers, Jonathan, Sehnert, Amy J., Edelberg, Jay M., Li, Wanying, Olivotto, Iacopo

Volltext

Stem Cells and the Regeneration of the Aging Cardiovascular System von Ballard, Victoria L.T, Edelberg, Jay M

Volltext

Loss of SR-BI Expression Leads to the Early Onset of Occlusive Atherosclerotic Coronary Artery Disease, Spontaneous Myocardial Infarctions, Severe Cardiac Dysfunction, and Prematur... von Braun, Anne, Trigatti, Bernardo L, Post, Mark J, Sato, Kaori, Simons, Michael, Edelberg, Jay M, Rosenberg, Robert D, Schrenzel, Mark, Krieger, Monty

Volltext

Young Adult Bone Marrow–Derived Endothelial Precursor Cells Restore Aging-Impaired Cardiac Angiogenic Function von Edelberg, Jay M, Tang, Lilong, Hattori, Koichi, Lyden, David, Rafii, Shahin

Volltext

Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy von Desai, Milind Y., Owens, Anjali, Geske, Jeffrey B., Wolski, Kathy, Naidu, Srihari S., Smedira, Nicholas G., Cremer, Paul C., Schaff, Hartzell, McErlean, Ellen, Sewell, Christina, Li, Wanying, Sterling, Lulu, Lampl, Kathy, Edelberg, Jay M., Sehnert, Amy J., Nissen, Steven E.

Volltext

Time-Dependent Cardiovascular Treatment Benefit Model for Lipid-Lowering Therapies von Khan, Irfan, Peterson, Eric D., Cannon, Christopher P., Sedita, Lauren E., Edelberg, Jay M., Ray, Kausik K.

Volltext

Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 ye... von Farnier, Michel, MD, PhD, Colhoun, Helen M., MD, MFPHM, FRCP(Ed), Sasiela, William J., PhD, Edelberg, Jay M., MD, PhD, Asset, Gaëlle, MSc, Robinson, Jennifer G., MD, MPH

Volltext

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy von Ho, Carolyn Y., Mealiffe, Matthew E., Bach, Richard G., Bhattacharya, Mondira, Choudhury, Lubna, Edelberg, Jay M., Hegde, Sheila M., Jacoby, Daniel, Lakdawala, Neal K., Lester, Steven J., Ma, Yanfei, Marian, Ali J., Nagueh, Sherif F., Owens, Anjali, Rader, Florian, Saberi, Sara, Sehnert, Amy J., Sherrid, Mark, Solomon, Scott D., Wang, Andrew, Wever-Pinzon, Omar, Wong, Timothy C., Heitner, Stephen B.

Volltext

Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial von Steg, Philippe Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Brégeault, Marie-France, Dalby, Anthony J, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lecorps, Guillaume, Mahaffey, Kenneth W, Moryusef, Angèle, Ostadal, Petr, Parkhomenko, Alexander, Pordy, Robert, Roe, Matthew T, Tricoci, Pierluigi, Vogel, Robert, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G

Volltext

Targeted disruption of cd39 /ATP diphosphohydrolase results in disordered hemostasis and thromboregulation von Rosenberg, Robert D, Enjyoji, Keiichi, Sévigny, Jean, Lin, Yuan, Frenette, Paul S, Christie, Patricia D, Esch, Jan Schulte Am, Imai, Masato, Edelberg, Jay M, Rayburn, Helen, Lech, Miroslaw, Beeler, David L, Csizmadia, Eva, Wagner, Denisa D, Robson, Simon C

Volltext

Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy von Desai, Milind Y., Wolski, Kathy, Owens, Anjali, Naidu, Srihari S., Geske, Jeffrey B., Smedira, Nicholas G., Schaff, Hartzell, Lampl, Kathy, McErlean, Ellen, Sewell, Christina, Zhang, David, Edelberg, Jay M., Sehnert, Amy J., Nissen, Steven E.

Volltext

The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review von Edelberg, Jay M., Sehnert, Amy J., Mealiffe, Matthew E., del Rio, Carlos L., McDowell, Robert

Volltext

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial von White, Harvey D, Steg, Ph Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Edelberg, Jay M, Erglis, Andrejs, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lopes, Renato D, Mahaffey, Kenneth W, Moryusef, Angele, Pordy, Robert, Roe, Matthew T, Sritara, Piyamitr, Tricoci, Pierluigi, Zeiher, Andreas M, Schwartz, Gregory G

Volltext

Assessment of Disease Status and Treatment Response With Artificial Intelligence-Enhanced Electrocardiography in Obstructive Hypertrophic Cardiomyopathy von Tison, Geoffrey H, Siontis, Konstantinos C, Abreau, Sean, Attia, Zachi, Agarwal, Priyanka, Balasubramanyam, Aarthi, Li, Yunfan, Sehnert, Amy J, Edelberg, Jay M, Friedman, Paul A, Olgin, Jeffrey E, Noseworthy, Peter A

Volltext

Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial von Voors, Adriaan A., Tamby, Jean‐François, Cleland, John G., Koren, Michael, Forgosh, Leslie B., Gupta, Dinesh, Lund, Lars H., Camacho, Albert, Karra, Ravi, Swart, Henk P., Pellicori, Pierpaolo, Wagner, Frank, Hershberger, Ray E., Prasad, Narayana, Anderson, Robert, Anto, Anu, Bell, Kaylyn, Edelberg, Jay M., Fang, Liang, Henze, Marcus, Kelly, Cynthia, Kurio, Gregory, Li, Wanying, Wells, Kate, Yang, Chun, Teichman, Sam L., Rio, Carlos L., Solomon, Scott D.

Volltext

Vascular Bed-Specific Expression of an Endothelial Cell Gene Is Programmed by the Tissue Microenvironment von Aird, William C., Edelberg, Jay M., Weiler-Guettler, Hartmut, Simmons, William W., Smith, Thomas W., Rosenberg, Robert D.

Volltext

Stem Cell Review Series: Regulating highly potent stem cells in aging: environmental influences on plasticity von Edelberg, Jay M., Ballard, Victoria L. T.

Volltext

Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population von Curtis, Anne M., Zhang, Lifeng, Medenilla, Elizabeth, Gui, Ming, Wilkinson, Patrick F., Hu, Erding, Giri, Jay, Doraiswamy, Vijay, Gunda, Sampath, Burgert, Mark E., Moore, Jonni S, Edelberg, Jay M., Mohler, Emile R.

Volltext

Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States von Jain, Sneha S., Li, Sophia S., Xie, Jipan, Sutton, Megan B., Fine, Jennifer T., Edelberg, Jay M., Gao, Wei, Spertus, John A., Cohen, David J.

Volltext

Effect of Alirocumab on Mortality After Acute Coronary Syndromes von Steg, Philippe Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Brégeault, Marie-France, Dalby, Anthony J, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lecorps, Guillaume, Mahaffey, Kenneth W, Moryusef, Angèle, Ostadal, Petr, Parkhomenko, Alexander, Pordy, Robert, Roe, Matthew T, Tricoci, Pierluigi, Vogel, Robert, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G

Volltext